Mechanisms underlying TAX-mediated neuroprotection against AD or CAA
Potential mechanisms underlying TAX-mediated neuroprotection against AD or CAA. In AD, TAX conferred neuroprotection via decreasing the level of cPLA2 to reduce the synthesis of PGE2, inhibiting neuroinflammation, suppressing the activation of APOE and ERK1/2 signaling to decrease Aβ production, up-regulating SIRT1 expression to inhibit Aβ-induced JAK-2/STAT3 pathway activation, and then decreasing BACE1 expression to ultimately inhibit Aβ aggregation in neurons. In CAA, TAX promoted the breakdown of Aβ, inhibited Aβ oligomer formation, cleared Aβ from the brain to the circulation, and restored the cerebral blood flow (CBF) and cerebrovascular reactivity (CVR)
Publication
New Perspectives of Taxifolin in Neurodegenerative Diseases (2023) Rong Yang, et al. Curr Neuropharmacol. 2023 Aug 15;21(10). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | SIRT1 | SIRT1 | ncbigene_symbol | SIRT1 | 23411 |
| Homo sapiens | Primates | APP | APP | ncbigene_symbol | APP | 351 |
| Homo sapiens | Primates | TAX | TAX | ncbigene_synonym | CNTN2 | 6900 |
| Homo sapiens | Primates | CAA | CAA | ncbigene_synonym | TSHZ1 | 10194 |
| Homo sapiens | Primates | APOE | APOE | ncbigene_symbol | APOE | 348 |
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | BACE1 | BACE1 | ncbigene_symbol | BACE1 | 23621 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| PGE2 | PGE2 | (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid | chebi:15551 | |
| APP | APP | chebi:147408 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|